查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701259

免疫檢測分析儀市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、地區、細分市場預測，2025-2030 年

Immunoassay Analyzers Market Size, Share & Trends Analysis Report By Product (Chemiluminescence Immunoassays, Fluorescence Immunoassay, Radioimmunoassay), By Application (Oncology, Cardiology), By End-use, By Region And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

免疫檢測分析儀市場趨勢：

預計 2024 年全球免疫檢測分析儀市值將達 71.8 億美元，預計 2025 年至 2030 年的複合年成長率為 4.13%。

慢性疾病（包括感染疾病和非感染疾病）的增加是免疫檢測分析儀市場成長的主要驅動力。隨著癌症、心血管疾病等疾病負擔的不斷加重，免疫測量分析儀的技術進步和應用範圍正在迅速擴大。這些進步在早期診斷、疾病監測和治療計劃中發揮關鍵作用。世界衛生組織 (WHO) 報告稱，2022 年將出現約 2,000 萬例新發癌症病例，預計未來幾年診斷數將達到 5,350 萬例。這些慢性疾病的快速成長刺激了對創新免疫測量解決方案的需求，主要企業正在致力於開發更先進、更有效的診斷技術。

COVID-19 疫情的爆發進一步凸顯了對快速且準確的診斷工具的需求。 SARS-CoV-2 病毒的出現迫切需要既準確又經濟的加速診斷方法。 RT-PCR 測試被廣泛用於早期檢測，但通常價格昂貴且耗費資源。因此，檢測抗體的免疫測量分析儀已被廣泛採用，提供了更具成本效益和效率的替代方案。公司對這項需求做出了快速反應，並推出了先進的免疫測量解決方案。例如，安捷倫科技公司推出了安捷倫Dako SARS-CoV-2酶聯免疫測量套件，用於檢測人類血清或血漿中的SARS-CoV-2抗體。這場疫情提高了人們對免疫測量分析儀功能的認知，並加速了科技和市場的發展。

慢性病的增加促使免疫檢測技術不斷進步。新感染疾病的出現、對抗生素抗藥性的日益擔憂以及對個人化醫療的需求不斷成長，推動了對高靈敏度、特異性和快速免疫測量測定測試的需求。公司正在投資創新解決方案來滿足這些不斷變化的醫療保健需求。例如，Diamond Diagnostics 致力於透過製造高品質、具成本效益的免疫檢測分析儀耗材和配件來增強免疫檢測診斷。這些技術創新為醫療保健專業人員提供了可靠和先進的診斷工具，從而促進了市場的擴張。

除了技術進步之外，主要企業之間的策略聯盟也對市場成長做出了重大貢獻。越來越多的公司正在建立合作夥伴關係，以加強免疫測量能力、支持治療方法進步並加速臨床應用。一個值得注意的例子是貝克曼庫爾特公司與FUJIREBIO於 2023 年 7 月建立的合作關係。此次合作旨在增強免疫檢測在神經退化性疾病研究、臨床試驗、常規診斷和報銷過程中的應用。透過整合專業知識和資源，這些聯盟推動了創新並提高了先進診斷解決方案的可近性。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章免疫檢測分析儀市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 免疫檢測市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
  • 案例研究

第4章免疫檢測分析儀市場：產品評估與趨勢分析

  • 2024年及2030年的市場佔有率
  • 細分儀表板
  • 市場波動分析
  • 2018-2030年市場規模與趨勢分析
  • 化學冷光免疫檢測（CLIA）
  • 螢光免疫分析法（FIA）
  • 免疫測量
  • 酵素免疫分析法
  • v 耗材及配件
  • 耗材及配件

第5章免疫檢測分析儀市場：應用評估與趨勢分析

  • 2024年及2030年的市場佔有率
  • 細分儀表板
  • 市場波動分析
  • 2018-2030年市場規模與趨勢分析
  • 治療藥物監測
  • 腫瘤學
  • 心臟病學
  • 內分泌學
  • 傳染病檢查
  • 自體免疫疾病
  • 其他

第6章免疫檢測分析儀市場：最終用途估計與趨勢分析

  • 2024年及2030年的市場佔有率
  • 細分儀表板
  • 市場波動分析
  • 2018-2030年市場規模與趨勢分析
  • 醫院和診所
  • 診斷實驗室
  • 研究組織

第7章免疫檢測分析儀市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 市場規模、預測趨勢分析，2018 年至 2030 年：
  • 北美洲
    • 北美：SWOT分析
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲：SWOT分析
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 亞太地區：SWOT分析
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 拉丁美洲：SWOT分析
    • 巴西
    • 阿根廷
  • 中東和非洲
    • MEA：SWOT分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • 主要客戶
    • 主要企業市場佔有率分析（2024年）
    • Siemens Healthineers AG
    • BIOMERIEUX
    • FAbbott
    • QuidelOrtho Corporation
    • Sysmex Corporation
    • BD
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd
    • Beckman Coulter, Inc.
    • DiaSorin SpA
Product Code: GVR-1-68038-992-0

Immunoassay Analyzers Market Trends:

The global Immunoassay analyzers market size was estimated at USD 7.18 billion in 2024 and is expected to grow at a CAGR of 4.13% from 2025 to 2030. The increasing prevalence of chronic diseases, including both infectious and non-infectious conditions, is a significant driver of market growth for immunoassay analyzers. As the burden of diseases such as cancer and cardiovascular conditions continues to rise, technological advancements and the application of immunoassay analyzers are expanding rapidly. These advancements play a crucial role in early diagnosis, disease monitoring, and treatment planning. The World Health Organization (WHO) reported approximately 20 million new cancer cases in 2022, with a projected increase in diagnoses reaching 53.5 million in the coming years. This surge in chronic illnesses is fueling the demand for innovative immunoassay solutions, leading companies to develop more advanced and effective diagnostic technologies.

The outbreak of the COVID-19 pandemic further emphasized the need for rapid and accurate diagnostic tools. The emergence of the SARS-CoV-2 virus created an urgent demand for accelerated diagnostic methods that could offer both precision and affordability. While RT-PCR tests were widely used for early detection, they were often considered expensive and resource-intensive. This led to the widespread deployment of immunoassay analyzers for detecting antibodies, providing a more cost-effective and efficient alternative. Companies responded swiftly to this demand by launching advanced immunoassay solutions. For instance, Agilent Technologies, Inc. introduced the Agilent Dako SARS-CoV-2 enzyme-linked immunoassay kit, designed to detect SARS-CoV-2 antibodies in human serum or plasma. The pandemic heightened awareness about the capabilities of immunoassay analyzers, accelerating technological developments and market expansion.

The increasing prevalence of chronic diseases has driven continuous advancements in immunoassay technologies. The emergence of new infectious diseases, growing concerns over antibiotic resistance, and the rising demand for personalized medicine have spurred the need for highly sensitive, specific, and rapid immunoassay tests. Various companies are investing in innovative solutions to meet these evolving healthcare needs. Diamond Diagnostics, for example, is committed to enhancing immunoassay diagnostics by manufacturing high-quality, cost-effective consumables and accessories for immunoassay analyzers. Such innovations contribute to the expansion of the market, ensuring that healthcare providers have access to reliable and advanced diagnostic tools.

In addition to technological advancements, strategic collaborations among key industry players are significantly contributing to market growth. Companies are increasingly forming partnerships to strengthen their immunoassay capabilities, support therapeutic advancements, and facilitate clinical adoption. A notable example is the collaboration between Beckman Coulter, Inc. and Fujirebio in July 2023. This partnership aims to enhance immunoassay applications in neurodegenerative disease research, clinical trials, routine diagnostics, and reimbursement processes. By combining expertise and resources, these collaborations are driving innovation and improving the accessibility of advanced diagnostic solutions.

Global Immunoassay Analyzers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global Immunoassay analyzers market report on the basis of product, application, end use, region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Chemiluminescence Immunoassays (CLIA)
  • Fluorescence Immunoassays (FIA)
  • Radioimmunoassay
  • Enzyme-Linked Immunoassay
  • Consumables and Accessories
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Therapeutic Drug Monitoring
  • Oncology
  • Cardiology
  • Endocrinology
  • Infectious Disease Testing
  • Autoimmune Disease
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Regional Outlook (Revenue in USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Immunoassay Analyzers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising Prevalence of chronic and infectious diseases
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Growing adoption of personalized products
      • 3.2.1.4. Growing investments and collaborations
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High costs and operational complexity
  • 3.3. Immunoassay Analyzers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
  • 3.4. Case Study

Chapter 4. Immunoassay Analyzers Market: Product Estimates & Trend Analysis

  • 4.1. Products Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Immunoassay Analyzers Market: Product Movement Analysis
  • 4.4. Immunoassay Analyzers Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.5. Chemiluminescence Immunoassays (CLIA)
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Fluorescence Immunoassays (FIA)
    • 4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Radioimmunoassay
    • 4.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Enzyme-Linked Immunoassay
    • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. vConsumables and Accessories
    • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Consumables and Accessories
    • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Immunoassay Analyzers Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Immunoassay Analyzers Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Therapeutic Drug Monitoring
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Cardiology
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Endocrinology
    • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Infectious Disease Testing
    • 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.10. Autoimmune Disease
    • 5.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Immunoassay Analyzers Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Immunoassay Analyzers Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals & Clinics
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Diagnostic Laboratories
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Research Institutes
    • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Immunoassay Analyzers Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. North America: SWOT Analysis
    • 7.5.2. U.S.
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/Reimbursement
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/Reimbursement
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/Reimbursement
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe: SWOT Analysis
    • 7.6.2. UK
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/Reimbursement
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/Reimbursement
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/Reimbursement
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/Reimbursement
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/Reimbursement
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/Reimbursement
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/Reimbursement
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Regulatory framework/Reimbursement
      • 7.6.9.3. Competitive scenario
      • 7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific: SWOT Analysis
    • 7.7.2. Japan
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/Reimbursement
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/Reimbursement
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/Reimbursement
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. Australia
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/Reimbursement
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. South Korea
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/Reimbursement
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Regulatory framework/Reimbursement
      • 7.7.7.3. Competitive scenario
      • 7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Latin America: SWOT Analysis
    • 7.8.2. Brazil
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/Reimbursement
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/Reimbursement
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. MEA: SWOT Analysis
    • 7.9.2. South Africa
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/Reimbursement
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/Reimbursement
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/Reimbursement
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key country dynamics
      • 7.9.5.2. Regulatory framework
      • 7.9.5.3. Competitive scenario
      • 7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Siemens Healthineers AG
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Services benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. BIOMERIEUX
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Services benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. FAbbott
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Services benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. QuidelOrtho Corporation
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Services benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Sysmex Corporation
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Services benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. BD
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Services benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Thermo Fisher Scientific Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Services benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. F. Hoffmann-La Roche Ltd
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Services benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Beckman Coulter, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Services benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. DiaSorin S.p.A.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Services benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America immunoassay analyzers market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe immunoassay analyzers market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Germany immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 21 Germany immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 22 UK immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 23 UK immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 25 France immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 26 France immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 27 France immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Italy immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 29 Italy immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Spain immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 32 Spain immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Denmark immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 35 Denmark immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Sweden immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 38 Sweden immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Norway immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 41 Norway immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 42 Norway immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific immunoassay analyzers market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 48 China immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 49 China immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Japan immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 51 Japan immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 52 Japan immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 54 India immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 55 India immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Australia immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 60 Australia immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Thailand immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 63 Thailand immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 64 Thailand immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 66 Latin America immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 67 Latin America immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Brazil immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 69 Brazil immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 70 Brazil immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Argentina immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 72 Argentina immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 73 Argentina immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 74 MEA immunoassay analyzers market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 76 MEA immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 77 MEA immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 78 South Africa immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 79 South Africa immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 80 South Africa immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 84 UAE immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 85 UAE immunoassay analyzers market, by application, 2018 - 2030 (USD Million)
  • Table 86 UAE immunoassay analyzers market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Kuwait immunoassay analyzers market, by product, 2018 - 2030 (USD Million)
  • Table 88 Kuwait immunoassay analyzers market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Immunoassay analyzers market: market outlook
  • Fig. 14 Immunoassay analyzers competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Immunoassay analyzers market driver impact
  • Fig. 20 Immunoassay analyzers market restraint impact
  • Fig. 21 Immunoassay analyzers market strategic initiatives analysis
  • Fig. 22 Immunoassay analyzers market: Product movement analysis
  • Fig. 23 Immunoassay analyzers market: Product outlook and key takeaways
  • Fig. 24 Chemiluminescence Immunoassays (CLIA) market estimates and forecast, 2018 - 2030
  • Fig. 25 Fluorescence Immunoassays (FIA) market estimates and forecast, 2018 - 2030
  • Fig. 26 Radioimmunoassay market estimates and forecast, 2018 - 2030
  • Fig. 27 Enzyme-Linked Immunoassay market estimates and forecast, 2018 - 2030
  • Fig. 28 Consumables and Accessories market estimates and forecast, 2018 - 2030
  • Fig. 29 Immunoassay analyzers Market: Application movement analysis
  • Fig. 30 Immunoassay analyzers market: Application outlook and key takeaways
  • Fig. 31 Therapeutic drug monitoring market estimates and forecasts, 2018 - 2030
  • Fig. 32 Oncology market estimates and forecasts, 2018 - 2030
  • Fig. 33 Cardiology market estimates and forecasts, 2018 - 2030
  • Fig. 34 Endocrinology market estimates and forecasts, 2018 - 2030
  • Fig. 35 Infectious disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 36 Autoimmune disease market estimates and forecasts, 2018 - 2030
  • Fig. 37 Others market estimates and forecasts, 2018 - 2030
  • Fig. 38 Immunoassay analyzers market: End use movement analysis
  • Fig. 39 Immunoassay analyzers market: End- use outlook and key takeaways
  • Fig. 40 Hospitals & clinics market estimates and forecasts, 2018 - 2030
  • Fig. 41 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 42 Research Institutes market estimates and forecasts, 2018 - 2030
  • Fig. 43 Global immunoassay analyzers market: Regional movement analysis
  • Fig. 44 Global immunoassay analyzers market: Regional outlook and key takeaways
  • Fig. 45 Global immunoassay analyzers market share and leading players
  • Fig. 46 North America market share and leading players
  • Fig. 47 Europe market share and leading players
  • Fig. 48 Asia Pacific market share and leading players
  • Fig. 49 Latin America market share and leading players
  • Fig. 50 Middle East & Africa market share and leading players
  • Fig. 51 North America: SWOT
  • Fig. 52 Europe SWOT
  • Fig. 53 Asia Pacific SWOT
  • Fig. 54 Latin America SWOT
  • Fig. 55 MEA SWOT
  • Fig. 56 North America, by country
  • Fig. 57 North America
  • Fig. 58 North America market estimates and forecasts, 2018 - 2030
  • Fig. 59 U.S.
  • Fig. 60 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 61 Canada
  • Fig. 62 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 63 Mexico
  • Fig. 64 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 65 Europe
  • Fig. 66 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 67 UK
  • Fig. 68 UK market estimates and forecasts, 2018 - 2030
  • Fig. 69 Germany
  • Fig. 70 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 71 France
  • Fig. 72 France market estimates and forecasts, 2018 - 2030
  • Fig. 73 Italy
  • Fig. 74 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 75 Spain
  • Fig. 76 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 77 Denmark
  • Fig. 78 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 79 Sweden
  • Fig. 80 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 81 Norway
  • Fig. 82 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 83 Asia Pacific
  • Fig. 84 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 85 China
  • Fig. 86 China market estimates and forecasts, 2018 - 2030
  • Fig. 87 Japan
  • Fig. 88 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 89 India
  • Fig. 90 India market estimates and forecasts, 2018 - 2030
  • Fig. 91 Thailand
  • Fig. 92 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 93 South Korea
  • Fig. 94 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 95 Australia
  • Fig. 96 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 97 Latin America
  • Fig. 98 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 99 Brazil
  • Fig. 100 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 101 Argentina
  • Fig. 102 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 103 Middle East and Africa
  • Fig. 104 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 105 South Africa
  • Fig. 106 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 107 Saudi Arabia
  • Fig. 108 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 109 UAE
  • Fig. 110 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 111 Kuwait
  • Fig. 112 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 113 Market share of key market players- Immunoassay analyzers market